Assignee
TOPADUR PHARMA AG
CH·7 granted patents·4 pending applications·0 citations·filing 2016–2025
Top patents by PatentIndex Score
11 records- 0183US12351585B22-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2023·Granted Jul 8, 2025·0 cites·20 claims
- 0276US11897890B22-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2021·Granted Feb 13, 2024·0 cites·8 claims
- 0374US2024360136A1Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2023·Application pending·0 cites
- 0471US11905293B2Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2021·Granted Feb 20, 2024·0 cites·21 claims
- 0571US2025320216A1Phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2025·Application pending·0 cites
- 0666US11242347B22-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2020·Granted Feb 8, 2022·0 cites·20 claims
- 0762US2025161309A1Topical compositions and uses therofTOPADUR PHARMA AG·Filed 2023·Application pending·0 cites
- 0856US10570137B22-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2016·Granted Feb 25, 2020·0 cites·20 claims
- 0954US11155558B2Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2018·Granted Oct 26, 2021·0 cites·20 claims
- 1053US2025000869A1Topical compositions of 2-phenyl-3, 4-dihydropyrrolo [2, l-f] [1, 2, 4] triazinone derivatives and uses thereofTOPADUR PHARMA AG·Filed 2022·Application pending·0 cites
- 1140US12502393B2Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2019·Granted Dec 23, 2025·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when TOPADUR PHARMA AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →